{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:20:26Z","timestamp":1792794026087,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Industrial Strategic Technology Development Program","award":["#10079271"],"award-info":[{"award-number":["#10079271"]}]},{"name":"Industrial Strategic Technology Development Program","award":["#20000134"],"award-info":[{"award-number":["#20000134"]}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"KHIDI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["# HL19C0020"],"award-info":[{"award-number":["# HL19C0020"]}],"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Collaborative Genome Program for Fostering New Post-Genome Industry","award":["NRF-2017M3C9A5031597"],"award-info":[{"award-number":["NRF-2017M3C9A5031597"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human epidermal growth factor receptor 2 (HER2) is often overexpressed in breast cancer and correlates with a worse prognosis. Thus, the accurate detection of HER2 is crucial for providing the appropriate measures for patients. However, the current techniques used to detect HER2 status, immunohistochemistry and fluorescence in situ hybridization (FISH), have limitations. Specifically, FISH, which is mandatory for arbitrating 2+ cases, is time-consuming and costly. To address this shortcoming, we established a multiple reaction monitoring-mass spectrometry (MRM-MS) assay that improves on existing methods for differentiating HER2 status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We quantified HER2 expression levels in 210 breast cancer formalin-fixed paraffin-embedded (FFPE) tissue samples by MRM-MS. We aimed to improve the accuracy and precision of HER2 quantification by simplifying the sample preparation through predicting the number of FFPE slides required to ensure an adequate amount of protein and using the expression levels of an epithelial cell-specific protein as a normalization factor when measuring HER2 expression levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>To assess the correlation between MRM-MS and IHC\/FISH data, HER2 quantitative data from MRM-MS were divided by the expression levels of junctional adhesion molecule A, an epithelial cell-specific protein, prior to statistical analysis. The normalized HER2 amounts distinguished between HER2 2+\/FISH-negative and 2+\/FISH-positive groups (AUROC = 0.908), which could not be differentiated by IHC. In addition, all HER2 status were discriminated by MRM-MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This MRM-MS assay yields more accurate HER2 expression levels relative to immunohistochemistry and should help to guide clinicians toward the proper treatment for breast cancer patients, based on their HER2 expression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvaa178","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T07:10:17Z","timestamp":1594883417000},"page":"1339-1348","source":"Crossref","is-referenced-by-count":38,"title":["Clinical Application of Multiple Reaction Monitoring-Mass Spectrometry to Human Epidermal Growth Factor Receptor 2 Measurements as a Potential Diagnostic Tool for Breast Cancer Therapy"],"prefix":"10.1093","volume":"66","author":[{"given":"Misol","family":"Do","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsoo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Injoon","family":"Yeo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyeon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Ae","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Suk","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngsoo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"Department of Biomedical Engineering, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"2020110419321102800_hvaa178-B1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"2020110419321102800_hvaa178-B2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ijc.2910450314","article-title":"Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues","volume":"45","author":"Natali","year":"1990","journal-title":"Int J Cancer"},{"key":"2020110419321102800_hvaa178-B3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"2020110419321102800_hvaa178-B4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1634\/theoncologist.2013-0283","article-title":"Human epidermal growth factor receptor family-targeted therapies in the treatment of HER2-overexpressing breast cancer","volume":"19","author":"Eroglu","year":"2014","journal-title":"Oncologist"},{"key":"2020110419321102800_hvaa178-B5","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J Clin Oncol"},{"key":"2020110419321102800_hvaa178-B6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/modpathol.3800774","article-title":"Standardization of HER2 testing: results of an international proficiency-testing ring study","volume":"20","author":"Dowsett","year":"2007","journal-title":"Mod Pathol"},{"key":"2020110419321102800_hvaa178-B7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/his.13801","article-title":"HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancer","volume":"74","author":"Tsai","year":"2019","journal-title":"Histopathology"},{"key":"2020110419321102800_hvaa178-B8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jval.2015.01.012","article-title":"The lifetime economic burden of inaccurate HER2 testing: Estimating the costs of false-positive and false-negative HER2 test results in US patients with early-stage breast cancer","volume":"18","author":"Garrison","year":"2015","journal-title":"Value Health"},{"key":"2020110419321102800_hvaa178-B9","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-09-0449","article-title":"Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancer","volume":"15","author":"Roepman","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2020110419321102800_hvaa178-B10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"26","author":"Wolff","year":"2007","journal-title":"J Clin Oncol"},{"key":"2020110419321102800_hvaa178-B11","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1001\/jama.291.16.1972","article-title":"HER-2 testing in breast cancer using parallel tissue-based methods","volume":"291","author":"Yaziji","year":"2004","journal-title":"JAMA"},{"key":"2020110419321102800_hvaa178-B12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/modpathol.3880154","article-title":"HER-2\/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach","volume":"13","author":"Ridolfi","year":"2000","journal-title":"Mod Pathol"},{"key":"2020110419321102800_hvaa178-B13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/jamaoncol.2018.6012","article-title":"Assessment of ERBB2\/HER2 status in HER2-equivocal breast cancers by FISH and 2013\/2014 ASCO-CAP guidelines","volume":"5","author":"Press","year":"2019","journal-title":"JAMA Oncol"},{"key":"2020110419321102800_hvaa178-B14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/pmic.201300311","article-title":"Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissues","volume":"14","author":"Steiner","year":"2014","journal-title":"Proteomics"},{"key":"2020110419321102800_hvaa178-B15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/path.5036","article-title":"Recent advances and opportunities in proteomic analyses of tumour heterogeneity","volume":"244","author":"Bateman","year":"2018","journal-title":"J Pathol"},{"key":"2020110419321102800_hvaa178-B16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/annonc\/mdw442","article-title":"Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment","volume":"28","author":"An","year":"2017","journal-title":"Ann Oncol"},{"key":"2020110419321102800_hvaa178-B17","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1373\/clinchem.2018.289702","article-title":"Clinical assay for AFP-L3 by using multiple reaction monitoring-mass spectrometry for diagnosing hepatocellular carcinoma","volume":"64","author":"Kim","year":"2018","journal-title":"Clin Chem"},{"key":"2020110419321102800_hvaa178-B18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpba.2018.04.025","article-title":"Fully validated SRM-MS-based method for absolute quantification of PIVKA-II in human serum: Clinical applications for patients with HCC","volume":"156","author":"Sohn","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"2020110419321102800_hvaa178-B19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/33.8.3894502","article-title":"Formaldehyde fixation","volume":"33","author":"Fox","year":"1985","journal-title":"J Histochem Cytochem"},{"key":"2020110419321102800_hvaa178-B20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jmoldx.2013.03.002","article-title":"Application of selected reaction monitoring for multiplex quantification of clinically validated biomarkers in formalin-fixed, paraffin-embedded tumor tissue","volume":"15","author":"Hembrough","year":"2013","journal-title":"J Mol Diagn"},{"key":"2020110419321102800_hvaa178-B21","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1074\/mcp.O115.049049","article-title":"Quantification of HER2 by targeted mass spectrometry in formalin-fixed paraffin-embedded (FFPE) breast cancer tissues","volume":"14","author":"Steiner","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"2020110419321102800_hvaa178-B22","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1021\/ac504689z","article-title":"Fast and sensitive total protein and peptide assays for proteomic analysis","volume":"87","author":"Wi\u015bniewski","year":"2015","journal-title":"Anal Chem"},{"key":"2020110419321102800_hvaa178-B23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1559-0275-9-5","article-title":"Selected reaction monitoring (SRM) analysis of epidermal growth factor receptor (EGFR) in formalin fixed tumor tissue","volume":"9","author":"Hembrough","year":"2012","journal-title":"Clin Proteomics"},{"key":"2020110419321102800_hvaa178-B24","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1038\/onc.2015.489","article-title":"HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR","volume":"35","author":"Ingthorsson","year":"2016","journal-title":"Oncogene"},{"key":"2020110419321102800_hvaa178-B25","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: An open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"2020110419321102800_hvaa178-B26","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1021\/pr5006636","article-title":"Panorama: A targeted proteomics knowledge base","volume":"13","author":"Sharma","year":"2014","journal-title":"J Proteome Res"},{"key":"2020110419321102800_hvaa178-B27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"Proteomexchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Vizcaino","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2020110419321102800_hvaa178-B28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/PAI.0b013e318205b03a","article-title":"Diagnostic value of automated Her2 evaluation in breast cancer: a study on 272 equivocal (score 2+) Her2 immunoreactive cases using an FDA approved system","volume":"19","author":"Cantaloni","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2020110419321102800_hvaa178-B29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/molbev\/msh010","article-title":"Mammalian housekeeping genes evolve more slowly than tissue-specific genes","volume":"21","author":"Zhang","year":"2004","journal-title":"Mol Biol Evol"},{"key":"2020110419321102800_hvaa178-B30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1373\/clinchem.2009.138420","article-title":"Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry","volume":"56","author":"Abbatiello","year":"2010","journal-title":"Clin Chem"},{"key":"2020110419321102800_hvaa178-B31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1074\/mcp.M113.036095","article-title":"Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach","volume":"13","author":"Carr","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"2020110419321102800_hvaa178-B32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2307\/2529748","article-title":"Use of the logistic model in retrospective studies","volume":"32","author":"Prentice","year":"1976","journal-title":"Biometrics"},{"key":"2020110419321102800_hvaa178-B33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nmeth.2763","article-title":"Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins","volume":"11","author":"Kennedy","year":"2014","journal-title":"Nat Methods"},{"key":"2020110419321102800_hvaa178-B34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1309\/99AE032R9FM8WND1","article-title":"HER2+ breast cancer: Review of biologic relevance and optimal use of diagnostic tools","volume":"129","author":"Hicks","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"2020110419321102800_hvaa178-B35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bios.2015.03.003","article-title":"A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells","volume":"69","author":"Kao","year":"2015","journal-title":"Biosens Bioelectron"},{"key":"2020110419321102800_hvaa178-B36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1373\/clinchem.2017.274266","article-title":"Improved detection of HER2 by a quasi-targeted proteomics approach using aptamer-peptide probe and liquid chromatography-tandem mass spectrometry","volume":"64","author":"Zhou","year":"2018","journal-title":"Clin Chem"},{"key":"2020110419321102800_hvaa178-B37","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1634\/theoncologist.2014-0195","article-title":"Gene status in HER2 equivocal breast carcinomas: impact of distinct recommendations and contribution of a polymerase chain reaction-based method","volume":"19","author":"Sapino","year":"2014","journal-title":"Oncologist"},{"key":"2020110419321102800_hvaa178-B38","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1021\/acs.jproteome.9b00686","article-title":"HYPERsol: High-quality data from archival FFPE tissue for clinical proteomics","volume":"19","author":"Marchione","year":"2020","journal-title":"J Proteome Res"},{"key":"2020110419321102800_hvaa178-B39","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/1878-0261.12570","article-title":"High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification","volume":"13","author":"Zhu","year":"2019","journal-title":"Mol Oncol"},{"key":"2020110419321102800_hvaa178-B40","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1021\/pr7008548","article-title":"Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis","volume":"7","author":"Cheng","year":"2008","journal-title":"J Proteome Res"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/advance-article-pdf\/doi\/10.1093\/clinchem\/hvaa178\/33738426\/hvaa178.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/66\/10\/1339\/33826191\/hvaa178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/66\/10\/1339\/33826191\/hvaa178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T20:51:26Z","timestamp":1604523086000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/66\/10\/1339\/5904418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,9,12]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvaa178","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,9,12]]}}}